Purchase Order 36C25025P0849

Award Date 6/16/25
Potential Completion Date 6/15/30
Potential Value $1.7M
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, provides reagents, test kits, instruments, and testing platforms to support the clinical diagnostic programs of the Department of Veterans Affairs (VA) Veterans Health Administration. The $105,552.60 firm-fixed-price delivery order contract has a completion date of September 30, 2018 and was awarded on October 1, 2017 by the VA's Veterans Integrated Service Network 23. The contract is not set...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Department of Veterans Affairs (VA). The contract, with a ceiling value of $1,526,412.82, is a delivery order that will run through January 18, 2025. It is a firm fixed-price contract for the provision of CEPHEID REAGENTS. The contract has no set-aside designation. Cepheid is the prime contractor and has previously been awarded other federal contracts and grants, including...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8. The contract is for the delivery of CEPHEID REAGENTS, a Firm Fixed Price Delivery Order with a ceiling value of $997,200.00 and a period of performance ending on June 8, 2026. The contract is not set aside for any specific business type. Cepheid has established itself as a critical provider of molecular...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the delivery of CEPHEID REAGENTS to the Department of Veterans Affairs (VA) Veterans Health Administration. The $209,274.30 firm-fixed-price purchase order was issued on April 1, 2018, with a completion date of March 31, 2019. The contract does not have a set-aside designation. Cepheid, as the prime contractor, provides a range of products and services to federal agencies, including...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of laboratory reagents and consumables. The contract has a ceiling value of $193,750.10 and is a Firm Fixed Price Delivery Order. The awarding agency is the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20, a civilian agency. This appears to be a continuation of Cepheid's existing relationships with the VA, as the company holds several Indefinite...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of CEPHEID REAGENTS AND SUPPLIES ORDERING PERIOD 5. The contract, valued at $446,106.15, is a firm fixed-price delivery order issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17. The contract does not have a set-aside designation and is primarily for the supply of GeneXpert diagnostic systems, molecular reagents, test kits, and...
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide reagents and consumables for the Puget Sound VA Medical Center. The award, valued at $830,739.00, has an ultimate completion date of November 30, 2024. Cepheid has been awarded multiple prime contracts and indefinite delivery vehicles (IDVs) with the VA to continuously provide its molecular diagnostic solutions, including...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 6. The contract is for the delivery of Cepheid's molecular diagnostic testing system reagents, assays, and equipment lease. The contract has a ceiling value of $41,403.06 and a performance period ending on March 31, 2025. This contract is a delivery order under a larger indefinite delivery vehicle...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $406,041.74, is for the delivery of reagents and test kits with a period of performance through March 31, 2024. This award is not associated with a set-aside program. Cepheid is a leading provider of molecular diagnostic equipment, reagents, and services to federal...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract, valued at $779,868.80, is for the provision of reagents and consumables for laboratory tests. The award is not associated with a set-aside program. Cepheid holds several significant federal contract Indefinite Delivery Vehicles (IDVs) with the VA and Indian Health Service, enabling...

This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10. The $1,666,318.75 firm fixed-price purchase order is for Cepheid reagents, with a performance period extending to June 15, 2030. Cepheid has also been awarded several Indefinite Delivery Vehicles (IDVs) with the VA and Indian Health Service, enabling continuous procurement of Cepheid's molecular diagnostic solutions, including equipment, reagents, test kits, and maintenance services, to support clinical testing programs across federal healthcare systems. This contract has no set-aside designation.

Generated 7/15/25, 4:08 PM